Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.137
-0.043 (-3.64%)
Nov 22, 2024, 4:00 PM EST - Market closed

Dermata Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-11.27-7.79-9.61-7.9-3.24-4.72
Depreciation & Amortization
----00
Other Amortization
---0.010.10.14
Stock-Based Compensation
0.760.520.931.91--
Other Operating Activities
-----0.130.73
Change in Accounts Payable
0.380.37-0.020.41-0.230.12
Change in Other Net Operating Assets
0.740.49-0.14-0.12-0.52-0.2
Operating Cash Flow
-9.4-6.41-8.83-5.69-4.03-3.92
Short-Term Debt Issued
---1.562.97-
Long-Term Debt Issued
----0.130.15
Total Debt Issued
---1.563.110.15
Long-Term Debt Repaid
----0.56-0.81-0.76
Net Debt Issued (Repaid)
---1.012.3-0.61
Issuance of Common Stock
8.917.614.2815.39--
Repurchase of Common Stock
-0-0----
Other Financing Activities
------0.01
Financing Cash Flow
8.917.614.2815.962.574.73
Net Cash Flow
-0.491.2-4.5610.27-1.460.81
Free Cash Flow
-9.4-6.41-8.83-5.69-4.03-3.92
Free Cash Flow Per Share
-12.52-32.87-191.86-317.61--
Cash Interest Paid
---00.060.1
Cash Income Tax Paid
000000
Levered Free Cash Flow
-5.51-3.64-5.59-2.49-2.76-
Unlevered Free Cash Flow
-5.51-3.64-5.59-2.48-2.74-
Change in Net Working Capital
-1.18-0.860.47-0.530.76-
Source: S&P Capital IQ. Standard template. Financial Sources.